Summary
The pharmacokinetics and bioavailability of 3 oral dyphylline preparations, solution (S), regular (R) and sustained release (SR), were studied in 8 healthy subjects (mean age 25 years). A single dose of each preparation, 20 mg·kg−1, was given at one week intervals and multiple serum samples obtained over 24 h. Drug levels were measured by high performance liquid chromatography. No adverse effects were found. The dyphylline half-life for the solution was 2.16±0.18 h and for the tablet 2.59±0.56 h. The mean clearance rate for S was 13.6±1.7 h−1 and volume of distribution 43.0±3.91. Peak concentration (Cmax, µg·ml−1), time of peak (Tmax, h), area under the curve (AUC, µg·ml−1·h) and relative bioavailability (RB, %), were determined for three preparations:
The data confirm the short half-life of dyphylline, demonstrate a lack of toxicity for the 20 mg·kg−1 dose and establish bioequivalence for the products studied.
This is a preview of subscription content, log in via an institution to check access.
References
Maney PV, Jones JW, Gross EG, Korns HM (1946) Dihydroxypropyl theophylline — Its preparation and pharmacological and clinical study. J Am Pharm Assoc 35:266–272
Levine ER (1965) An effective oral medication for long-term bronchodilation. Ann Allergy 23:403–413
Ouellette JJ, Kriz RJ, Kooistra JB (1980) Efficacy and tolerability of dyphylline in bronchial asthma: A retrospective survey. Curr Ther Res 27:844–851
Hendeles L, Weinberger M (1977) Dyphylline (1977). The untheophylline xanthine brochodilator. Drug Intell Clin Pharm 11:424
Hendeles L, Weinberger M (1980) Poor absorption of an untheophylline xanthine bronchodilator. (Letter) Am J Hosp Pharm 37:169
Simons FER, Simons KJ, Bierman CW (1975) The pharmacokinetics of dihydroxypropyltheophylline — a basis for rational therapy. J Allergy Clin Immunol 56:347–355
Simons KJ, Simons FER, Bierman CW (1977) Bioavailability of a sustained-release dyphylline formulation. J Clin Pharmacol 17:237–242
Gisclon LG, Ayres JW, Ewing GH (1979) Pharmacokinetics of orally administered dyphylline. Am J Hosp Pharm 36:1179–1184
Hudson LD, Tyler ML, Petty TL (1973) Oral aminophylline and diphydroxypropyl theophylline in reversible obstructive airway disease — a single dose double-blind crossover comparison. Curr Ther Res 15:367–372
Simons FER, Bierman CW, Sprenkle AC, Simons KT (1975) Efficacy of dyphylline in exercise-induced bronchospasm. Pediatrics 56 [Suppl]:916–918
Furukawa CT, Shapiro GG, Weliky I, Pierson WE, Bierman CW (1982) Double blind evaluation of dyphylline, theophylline and placebo for exercise induced bronchospasm. (Abstract) J Allergy Clin Immunol 69:136
Lawyer CH, Bardana EJ, Rodgers R, Micholas (1980) Utilization of i.v. dihydroxypropyl theophylline (dyphylline) in an aminophylline sensitive patients and its pharmacokinetics comparison with theophylline. J Allergy Clin Immunol 65:353
Zar JH (1974) Biostatistical analysis. Prentice-Hall, Englewood Cliffs, New Jersey, p 198
McColl JD, Parker JM, Ferguson JKW (1956) A comparison of the relative toxic, emetic, and convulsive actions of a series of methylated xanthine derivatives. J Pharmacol Exp Ther 116:343–350
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stablein, J.J., Samaan, S.S., Bukantz, S.C. et al. Pharmacokinetics and bioavailability of three dyphylline preparations. Eur J Clin Pharmacol 25, 281–283 (1983). https://doi.org/10.1007/BF00543805
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00543805